v3.23.1
Business acquisition - Assets acquired and liabilities assumed (Details) - USD ($)
$ in Thousands
1 Months Ended
Dec. 01, 2021
Jun. 14, 2021
Jan. 31, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2020
Liabilities assumed            
Goodwill       $ 85,811 $ 22,434 $ 1,138
AbX Biologics, Inc.            
Assets acquired            
Cash and cash equivalents $ 1,306          
Accounts receivable 2,309          
Other current assets and prepaid expenses 1,654          
Property, plant and equipment 1,078          
Other non-current assets 2,970          
Intangible assets 46,500          
Liabilities assumed            
Current liabilities 3,549          
Non-current liabilities 846          
Deferred tax liability 10,545          
Fair value of assets acquired and liabilities assumed 40,877          
Goodwill 61,768          
Total purchase price 102,645          
Consideration transferred            
Cash 9,467          
Company common stock 72,514          
Contingent consideration 8,500          
Net working capital adjustment (674)          
Indemnity holdback 12,838          
Fair value of purchase consideration 102,645          
iGenomX            
Assets acquired            
Cash and cash equivalents   $ 7        
Accounts receivable   37        
Inventories   14        
Intangible assets   18,410        
Liabilities assumed            
Accounts payable   57        
Accrued expenses   44        
Deferred tax liability   2,252        
Fair value of assets acquired and liabilities assumed   37,653        
Goodwill   21,538        
Consideration transferred            
Cash   490        
Company common stock $ 66,100 26,772 $ 4,600      
Contingent consideration   5,467        
Indemnity holdback   4,924        
Fair value of purchase consideration   $ 37,653